TABLE 2.
Species | Diseases | Region | lncRNA | Change | miRNA | Expression | Target gene | Change | Functions | References | |
(1) | Rat | RA | Synovial tissues | PVT1 | Up | miR-543 | Down | SCUBE2 | Up | Cell proliferation and apoptosis | Wang et al., 2020 |
(2) | Human | RA | Synovial tissues | LINC-PINT | Down | miR-155-5p | Up | SOCS1 | Down | Cell proliferation and invasion | Wang and Zhao, 2020 |
(3) | Human | RA | Serum | HIX003209 | Up | miR-6089 | Down | TLR4 | Up | Inflammation | Yan et al., 2019 |
(4) | Human | AS | Serum, fibroblast-like synovial cells | lncRNA MEG3 | Down | miR-146a | Up | – | – | Inflammation | Li Y. et al., 2020 |
(5) | Human | AS | Peripheral blood mononuclear cells | H19 | Up | miR675-5p/miR22-5p | miR675-5p up; miR22-5p down | VDR | Up | Inflammation | Zhang et al., 2020f |
AS, ankylosing spondylitis; MEG3, maternally expressed gene 3; PINT, p53-induced transcript; PVT1, plasmacytoma variant translocation 1; RA, rheumatoid arthritis; SCUBE2, signal peptide-CUB-EGF-like containing protein 2; SOCS1, cytokine signaling 1.